POLYSEROSITIS AS A MASK OF PARAPROTEINEMIC HEMOBLASTOSIS

O N Novikova , N V Alekseeva , E A Rudenko

Journal of Clinical Practice ›› 2014, Vol. 5 ›› Issue (3) : 59 -65.

PDF
Journal of Clinical Practice ›› 2014, Vol. 5 ›› Issue (3) : 59 -65. DOI: 10.17816/clinpract5359-65
Articles
review-article

POLYSEROSITIS AS A MASK OF PARAPROTEINEMIC HEMOBLASTOSIS

Author information +
History +
PDF

Abstract

The article describes the rare clinical case of Waldenstr`m's macroglobulinemia in combination with primary amyloidosis which main clinical symptom is polyserositis. The diagnostic difficulties of this case are described.

Keywords

Waldenstr`m's macroglobulinemia / polyserositis / primary amyloidosis

Cite this article

Download citation ▾
O N Novikova, N V Alekseeva, E A Rudenko. POLYSEROSITIS AS A MASK OF PARAPROTEINEMIC HEMOBLASTOSIS. Journal of Clinical Practice, 2014, 5(3): 59-65 DOI:10.17816/clinpract5359-65

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Waldenström J. Incipient myelomatosis or "essential" hyperglobulinemia with fibrinogenopenia - a new syndrome? Acta Med. Scand, 1944, v. 117, p. 216-47.

[2]

Kyle R.A. Waldenström's macroglobulinemia. In: Myeloma. Biology and Management / Malpas J.S., Bergsagel D.E., Kyle R.A. eds. Oxford: Univers. Press, 1995, p. 543-64.

[3]

Groves F., Travis L., Devesa S., et al. Waldenström's macroglobulinemia: incidence patterns in the United States, 1988-1994. Cancer, 1998, v. 82, p. 1078-81.

[4]

McMaster M.L. Familial Waldenström's macroglobulinemia. Semin Oncol., 2003, v. 30, p. 146-52.

[5]

Treon S.P., Hunter Z., Aggarwal A., et al. Characterization of familial Waldenström's macroglobulinemia. Ann Oncol. 2006, v. 17, p. 488-94.

[6]

Landgren O., Gridley G., Engels E.A., et al. Chronic immune stimulation and subsequent Waldenström's macroglobulinemia. Proceedings of the 5th International Workshop on Waldenström's macroglobulinemia, Stockholm, Sweden 2008 (Adstract 118).

[7]

Swerdlow S.H., Berger F., Pileri S.A., et al. Lymphoplasmacytic lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues / S.H. Swerdlow, E. Campo, N.L. Harris, E.S. Jaffe, S.A. Pileri, H. Stein, J. Thiele, J.W. Vardiman, eds. Lyon: IARC Press, 2008, p. 194-95.

[8]

Андреева Н.Е., Балакирева Т. В. Mакроглобулинемия Вальденстрема // Клиническая онкогематология / Под ред. М.А. Волковой. Издание второе. М.: Медицина, 2007. с. 874-84.

[9]

Dimopoulos M.A., Kyle R., Anagnostopoulos A., Treon S.P. Diagnosis and management of Waldenström's macroglobulinemia. J Clin Oncol., 2005, v. 23, p. 1564-77.

[10]

Berman H. H. Waldenström's macroglobulinemia with lytic osseous lesions and plasma cell morphology. Am. J. Clin. Pathol., 1975, v. 63, p. 397-402.

[11]

Bj`rkholm M. Lymphoplasmacytic lymphoma / Waldenström's macroglobulinemia. In: The Lymphomas /G.P. Cannelos, T.A. Lister, B. Young, eds. Saunders: Elsevier. 2-nd Ed., 2006, p. 374-80.

[12]

Gertz M.A., Kyle R.A., Noel P. Primary systemic amyloidosis: a rare complication of immunoglobulin M monoclonal gammopathies and Waldenström's macroglobulinemia. J Clin Oncol, 1993, v. 11, p. 914-20.

[13]

Gertz M.A., Kyle R.A. Amyloidosis with IgM monoclonal gammopathies. Semin Oncol, 2003, v. 30, p. 325-28.

[14]

Berk JL, Keane J, Seldin DC, et al. Persistent pleural effusions in primary systemic amyloidosis. Chest 2003; 124; 969-77.

RIGHTS & PERMISSIONS

Novikova O.N., Alekseeva N.V., Rudenko E.A.

AI Summary AI Mindmap
PDF

44

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/